Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe Not

  1. González-Padilla, D.A.
  2. Subiela, J.D.
Aldizkaria:
European Urology

ISSN: 1873-7560 0302-2838

Argitalpen urtea: 2024

Alea: 85

Zenbakia: 1

Orrialdeak: 1-2

Mota: Editoriala

DOI: 10.1016/J.EURURO.2023.05.017 GOOGLE SCHOLAR